Construction of a globally modular recombinant Saccharomyces cerevisiae chassis for ginkgolide precursor levopimaradiene production
Synthetic and Systems Biotechnology · 2026-09 · 13 · 154-162
DOI: 10.1016/j.synbio.2026.01.018 ↗Kurz gefasst
Fachartikel in der Zeitschrift Synthetic and Systems Biotechnology, 2026-09. Verfasst von De Liu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Biotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou, 511443, China. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 48 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Guangdong Provincial Natural Science Foundation.
Abstract (Originalsprache)
The production of biologically active natural products through microbial metabolic factories, such as Saccharomyces cerevisiae , represents a promising approach to achieving green and sustainable production. However, establishing a stable metabolic flux for natural products by disrupting the natural evolutionary pathways of S. cerevisiae remains a significant challenge. This phenomenon is often associated with strain growth stagnation, presenting a key bottleneck in metabolic engineering. Here, we successfully devised a recombinant S. cerevisiae chassis strain capable of producing levopimaradiene (LP), a critical precursor for ginkgolide biosynthesis. By systematically modifying levopimaradiene synthase (LPS), modulating the mevalonate pathway, and enhancing the supply of acetyl-coenzyme A, ATP, and NADPH, we significantly improved the titer of LP. Shake flask fermentation achieved a LP titer of 792.72 ± 69.59 mg/L, while fed-batch fermentation further elevated the titer to 1809.32 ± 72.32 mg/L. This represents a 8.3-fold increase over the previously reported S. cerevisiae chassis strain, corresponding to the highest titer reported to date. This study provides a strategy for the construction of ginkgolide chassis factories. Moreover, it offers a conceptual framework for the construction of factories for the production of diterpene, with a particular focus on the field of S. cerevisiae production.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Biotechnological Institute of Chinese Materia Medica, Jinan University, Guangzhou, 511443, China.
- Department of Natural Product Chemistry, Jinan University, Guangzhou, 511443, China.
Förderung
- National Natural Science Foundation of China
- Guangdong Provincial Natural Science Foundation
Zitieren
APA
Liu, Chen, Z., Guo, Z., Xue, Q., He, Q., Yu, R., & Zhu, J. (2026). Construction of a globally modular recombinant Saccharomyces cerevisiae chassis for ginkgolide precursor levopimaradiene production. Synthetic and Systems Biotechnology, 13, 154-162. https://doi.org/10.1016/j.synbio.2026.01.018
Vancouver
Liu, Chen Z, Guo Z, Xue Q, He Q, Yu R, et al. Construction of a globally modular recombinant Saccharomyces cerevisiae chassis for ginkgolide precursor levopimaradiene production. Synthetic and Systems Biotechnology. 2026;13:154-162. doi:10.1016/j.synbio.2026.01.018
BibTeX
@article{Liu2026,
author = {Liu, De and Chen, Ziqing and Guo, Zizheng and Xue, Qihang and He, Qiulin and Yu, Rongmin and Zhu, Jianhua},
title = {Construction of a globally modular recombinant Saccharomyces cerevisiae chassis for ginkgolide precursor levopimaradiene production},
journal = {Synthetic and Systems Biotechnology},
year = {2026},
volume = {13},
pages = {154--162},
doi = {10.1016/j.synbio.2026.01.018}
}
EUVIMED